成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 6326-27-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 6326-27-8
Chemical Structure| 6326-27-8
Structure of 6326-27-8 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 6326-27-8 ]

Related Doc. of [ 6326-27-8 ]

Alternatived Products of [ 6326-27-8 ]
Product Citations

Product Details of [ 6326-27-8 ]

CAS No. :6326-27-8 MDL No. :MFCD00040183
Formula : C8H11ClN2 Boiling Point : No data available
Linear Structure Formula :- InChI Key :MTDUPZAXNYELOU-UHFFFAOYSA-N
M.W : 170.64 Pubchem ID :122753
Synonyms :

Calculated chemistry of [ 6326-27-8 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 2.0
Molar Refractivity : 49.64
TPSA : 49.87 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.87 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 2.07
Log Po/w (WLOGP) : 2.08
Log Po/w (MLOGP) : 2.25
Log Po/w (SILICOS-IT) : 1.57
Consensus Log Po/w : 1.59

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.54
Solubility : 0.492 mg/ml ; 0.00289 mol/l
Class : Soluble
Log S (Ali) : -2.75
Solubility : 0.306 mg/ml ; 0.00179 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.48
Solubility : 0.559 mg/ml ; 0.00327 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 6326-27-8 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 6326-27-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 6326-27-8 ]

[ 6326-27-8 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 57297-29-7 ]
  • [ 6326-27-8 ]
  • [ 1251249-97-4 ]
  • 2
  • [ 887581-09-1 ]
  • [ 6326-27-8 ]
  • [ 1255516-30-3 ]
YieldReaction ConditionsOperation in experiment
71% General procedure: A 25 mL Schlenk tube wascharged with a magnetic stirrer and DMSO (2.0 mL). Substituted(2-bromophenyl)methylamine (1) (0.5 mmol), amidine hydrochloride (2) (1.0 mmol),CuBr (0.1 mmol, 14.2 mg), and K2CO3 (1.5 mmol, 207 mg) were added to the tube.The mixture was stirred at 80-120 oC under nitrogen atmosphere for 24 h, and thenunder air for 0.5 h. The resulting mixture was cooled to room temperature and filtered,and the solid was washed with ethyl acetate for two times (3 × 3 mL). The combinedfiltrate was concentrated by the rotary evaporator, and the residue was purified bycolumn chromatography on silica gel using petroleum ether/ ethyl acetate as eluent togive the desired target product.
  • 3
  • [ 747392-34-3 ]
  • [ 6326-27-8 ]
  • [ 1600535-93-0 ]
YieldReaction ConditionsOperation in experiment
62% With potassium phosphate; copper(l) iodide; Trimethylacetic acid; In 1,2-dichloro-benzene; at 110℃; for 18h;Sealed tube; General procedure: Anoven-dried 10mLvialwas charged with CuI (9mg, 0.05mmol),K3PO4 (318 mg, 1.5 mmol), pivalic acid (20 mg, 0.2 mmol), a 1-(2-bromophenyl)methanamine 1 (0.5 mmol), and an amidinium salt 2or an imidate salt 4 (0.5 mmol) under air. After sealing the vial, dry1,2-dichlorobenzene (3 mL) was added by syringe and the reactionmixture was stirred at 110 C (oil bath temperature) for 18 h. Aftercooling to room temperature, the vial was opened and the reactionmixturewas partitioned between CH2Cl2 (30 mL) and brine (20 mL).The aqueous phase was extracted with CH2Cl2 (220 mL). Thecombined organic layers were dried over anhydrous MgSO4 andconcentrated in vacuum. The residue was purified by flash chromatographyon silica gel to afford the desired product.
  • 4
  • [ 6967-82-4 ]
  • [ 6326-27-8 ]
  • [ 82256-07-3 ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 6326-27-8 ]

Aryls

Chemical Structure| 1670-14-0

[ 1670-14-0 ]

Benzimidamide hydrochloride

Similarity: 1.00

Chemical Structure| 20680-59-5

[ 20680-59-5 ]

3-Methylbenzimidamide hydrochloride

Similarity: 1.00

Chemical Structure| 206752-36-5

[ 206752-36-5 ]

Benzenecarboximidamide hydrochloride hydrate

Similarity: 0.97

Chemical Structure| 618-39-3

[ 618-39-3 ]

Benzimidamide

Similarity: 0.97

Chemical Structure| 111082-23-6

[ 111082-23-6 ]

[1,1'-Biphenyl]-4-carboximidamide hydrochloride

Similarity: 0.91

Amidines

Chemical Structure| 1670-14-0

[ 1670-14-0 ]

Benzimidamide hydrochloride

Similarity: 1.00

Chemical Structure| 20680-59-5

[ 20680-59-5 ]

3-Methylbenzimidamide hydrochloride

Similarity: 1.00

Chemical Structure| 206752-36-5

[ 206752-36-5 ]

Benzenecarboximidamide hydrochloride hydrate

Similarity: 0.97

Chemical Structure| 618-39-3

[ 618-39-3 ]

Benzimidamide

Similarity: 0.97

Chemical Structure| 111082-23-6

[ 111082-23-6 ]

[1,1'-Biphenyl]-4-carboximidamide hydrochloride

Similarity: 0.91

Amines

Chemical Structure| 1670-14-0

[ 1670-14-0 ]

Benzimidamide hydrochloride

Similarity: 1.00

Chemical Structure| 20680-59-5

[ 20680-59-5 ]

3-Methylbenzimidamide hydrochloride

Similarity: 1.00

Chemical Structure| 206752-36-5

[ 206752-36-5 ]

Benzenecarboximidamide hydrochloride hydrate

Similarity: 0.97

Chemical Structure| 618-39-3

[ 618-39-3 ]

Benzimidamide

Similarity: 0.97

Chemical Structure| 111082-23-6

[ 111082-23-6 ]

[1,1'-Biphenyl]-4-carboximidamide hydrochloride

Similarity: 0.91

; ;